Literature DB >> 22541603

Clinical inertia: viewpoints of general practitioners and diabetologists.

A Avignon1, C Attali, A Sultan, E Ferrat, J Le Breton.   

Abstract

Large clinical studies have enabled best practice guidelines to be issued. Intended to serve practitioners in their daily practice, the guidelines are also excellent tools for assessing physician performance. It was therefore demonstrated that despite the observation of insufficient glycaemic control, physicians did not systematically increase drug treatments. As a result, they have been accused of clinical inertia! In this journal, we first try to reveal what is behind this concept and to differentiate true inertia from pseudo inertia. Secondly, we consider how general practitioners and diabetologists, through their respective positions, can develop a synergy that is able to fight against inertia but that can especially, improve the glycaemic control of our patients.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22541603     DOI: 10.1016/S1262-3636(12)71535-5

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  3 in total

1.  Therapeutic Inertia: Still a Long Way to Go That Cannot Be Postponed.

Authors:  Manel Mata-Cases; Josep Franch-Nadal; Mònica Gratacòs; Dídac Mauricio
Journal:  Diabetes Spectr       Date:  2020-02

2.  Therapeutic Inertia in Pediatric Diabetes: Challenges to and Strategies for Overcoming Acceptance of the Status Quo.

Authors:  Sarah D Corathers; Daniel J DeSalvo
Journal:  Diabetes Spectr       Date:  2020-02

3.  Intensification to injectable therapy in type 2 diabetes: mixed methods study (protocol).

Authors:  Simon de Lusignan; William Hinton; Emmanouela Konstantara; Neil Munro; Martin Whyte; Julie Mount; Michael Feher
Journal:  BMC Health Serv Res       Date:  2019-05-03       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.